Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

BloodNet system interface

  • Home
  • Access and ordering
  • BloodNet system interface

Interface your LIS with BloodNet

To save time and reduce keying errors, you can interface your facility's laboratory information system (LIS) with BloodNet.

Interfacing your LIS means you'll have easy access to near real-time blood inventory and stock movement information.

A BloodNet-to-LIS interface saves you significant processing time because you don't need to duplicate stock data into your LIS after you've entered it into BloodNet. BloodNet will update your LIS automatically, saving time and reducing keying errors. Many facilities have cut down the time it takes to order stock and manage their inventory by more than 90%.

When you interface with BloodNet, your LIS can:

  • receipt stock and add unit details into BloodNet when orders arrive from Australian Red Cross Lifeblood(Opens in a new tab/window) (Lifeblood)
  • automatically update inventory numbers in BloodNet, so you can see near real-time stock levels when ordering
  • upload your unit transfer, discard or transfusion data to BloodNet.

Interfacing with BloodNet also increases the speed and quality of data transfer between blood sector stakeholders.

This helps us improve:

  • supply planning
  • budget development
  • usage reporting
  • data analysis.

The BloodNet interface data flow diagram shows how the interface works to help medical officers, facility staff and suppliers.

  • BloodNet interface data flow diagram
    1.1 MB

Find out more about BloodNet.

BloodSTAR integration

The BloodSTAR integration allows you to transfer immunoglobulin (Ig) dispense data from your LIS into BloodNet and BloodSTAR. This means you can dispense Ig products almost entirely within your LIS because BloodNet will automatically dispense and update BloodSTAR.

It also means checks to resolve dispense discrepancies or unmatched episodes will be much quicker.

Adding a BloodSTAR integration to your BloodNet-to-LIS interface can save up to 75% of your time for each dispensing process.

This diagram shows the benefits and potential time savings when you enable our BloodSTAR integration.

A LIS BloodNet link with BloodSTAR integration saves up to 2 minutes of dispensing time per Ig product through automation of manual steps to sign into BloodNet, locate request, select dispense episode, scan or enter product lot number and save the dispense episode.
BloodSTAR Integration Diagram

Find out more about BloodSTAR.

BloodSTAR integration for new interfaces

We include BloodSTAR integration when you set up your BloodNet-to-LIS interface. There are additional BloodSTAR verification steps as part of your testing.

BloodSTAR integration for existing interfaces

If you already have a BloodNet-to-LIS interface and you want to enable the BloodSTAR integration, please email support@blood.gov.au or call 1300 025 663.

Certified LIS vendors

To ensure all BloodNet-to-LIS interfaces operate correctly, we have a LIS verification and certification process. This makes sure all LIS interfaces can communicate as expected with our BloodNet system.

All certified vendors have verified and tested their BloodNet-to-LIS interfaces to ensure their facility integration works.

Only certified vendors can use our BloodNet–LIS interface certified logo.

BloodNet LIS interface certified
BloodNet LIS interface certified

These LIS vendors have completed our LIS interface certification.

LIS vendorVersionNotes
eBloodv3.3This certification is subject to two exceptions for UnitFate Codes 7 'Reserve' and 9 `Convert’. Separately not sending ‘FatedBy’ data.
AUSLABvAUSLAB-2017-Q1This certification is subject to two exceptions for UnitFate Codes 7 'Reserve' and 8 'SentTo'.
BloodTrackv4.10–
Cirdan ULTRAV4.6.16This certification is subject to four exceptions for UnitFate Codes 6 `Assumed Transfused’, 7 'Reserve', 8 `SentTo’ and 9 `Convert’.
TrakCare LaboratoryL2012 v3.3–
SoftBankv 25.7.0.0This certification is subject to three exceptions for UnitFate Codes 7 'Reserve' and 8 'SentTo' and 9 'Convert'. Separately UnitFate Code 6 'AssumedTransfused' also only runs once per day and does not poll regularly in real time.
EVOLUTIONv5–
Oracle Millenniumv2018.11.07This certification is subject to three exceptions for UnitFate Codes 6 `Assumed Transfused’, 8 `SentTo’ and 9 `Convert’.

Technical specification for interfacing

Our technical specification covers the technical details for each data element of our BloodNet-to-LIS interface.

All types of LIS software must use this specification.

LIS vendors should refer to our technical specification when setting up, testing and verifying their systems.

  • Bloodnet LIS interface specifications
    2.16 MB

Certifying your LIS interface

It's vital that all BloodNet to LIS interfaces operate correctly. If you're a LIS vendor, you must pass our vendor and facility certification before we can enable your interface to operate.

To pass the certification, you must verify that your LIS will work as expected in the production environment.

Once you pass our certification, we'll issue production credentials. Then you can enable your BloodNet-to-LIS interface to operate in your client's facility.

Verifying your LIS

Before we allow your LIS interface to operate in a production environment, we need to verify it in our test environments.

There are 2 stages to verifying your LIS:

  1. Vendor verification
  2. Facility verification

With vendor verification, you'll test your LIS interface in our vendor BloodNet system integration testing (SIT) environment to ensure it communicates as expected with our BloodNet LIS web services.

Once you've successfully tested your LIS at the vendor level, you'll test it again in a facility BloodNet user acceptance testing (UAT) environment to ensure it still communicates as expected with our BloodNet LIS web services.

We must confirm and certify your vendor verification before you can begin testing in the facility BloodNet UAT environment.

Before you can test and verify your LIS, you must:

  1. Have each new LIS administrator create their user account in BloodPortal(Opens in a new tab/window).
  2. Provide written approval from every Australian Health Provider (AHP) whose data will be accessible in BloodNet.
  3. Fill out and submit the LIS interface sign-up form with your AHP approvals.

Once you've completed these steps and we've approved your vendor BloodNet SIT environment access, you can start your vendor verification process.

  • BloodNet LIS Interface sign-up form
    766.93 KB

Stage 1: Vendor verification

The vendor BloodNet SIT environment is: https://sit.blood.gov.au/BloodNet5/LISService/LISService.svc(Opens in a new tab/window)

The corresponding BloodNet website is: https://sit.blood.gov.au/BloodNet5/Web(Opens in a new tab/window)

The vendor BloodNet SIT environment is available 24 hours a day, 7 days a week. Our support hours for test environments are Monday to Friday from 9:00 am to 5:00 pm Canberra time.

If we plan any changes or outages to the test environment, we'll email all LIS administrators, developers and designated contact officers.

Stage 2: Facility verification

The facility BloodNet UAT environment is: https://uat.blood.gov.au/BloodNet5/LISService/LISService.svc(Opens in a new tab/window)

The corresponding BloodNet website for user acceptance testing is: https://uat.blood.gov.au/BloodNet5/Web(Opens in a new tab/window)

The facility BloodNet UAT environment is available 24 hours a day, 7 days a week. Our support hours for test environments are Monday to Friday from 9:00 am to 5:00 pm Canberra time.

If we plan any changes or outages to the test environment, we'll email all LIS administrators, developers and designated contact officers.

Verification test scenarios

For both vendor and facility verification, you need to run the following scenario testing (Scenarios A, B and C).

After testing in the vendor BloodNet SIT environment, you must send us your report for us to confirm and verify.

You can't begin testing in the facility BloodNet UAT environment until we've certified your vendor verification tests.

After testing in the facility BloodNet UAT environment, you must send us your report for us to confirm and verify.

Scenario A: Acknowledging issue notes

In this scenario, the facility will acknowledge some receipted issue notes.

  1. The facility will call the GetReceiptedIssueNotes web service method to return a list of receipted issue notes awaiting acknowledgement.
  2. The facility then calls the AcknowledgeReceiptedIssueNotes web service method to acknowledge the returned issue notes (from the GetReceiptedIssueNotes).

You can verify the scenario when the:

  • web service method calls are successful
  • LIS log page on the BloodNet website lists the acknowledged issue notes
  • information on the receipting web page shows the acknowledged issue notes.

We'll then confirm these results on at least 5 calls and 50 issue notes.

Scenario B: Update inventory levels

In this scenario, the facility will send up-to-date information on its stock levels.

  1. The facility will call the UpdateRealTimeInventoryLevels web service method with its stock levels.

You can verify the scenario when the:

  • web service method call is successful
  • LIS log page on the BloodNet website lists the stock update details
  • inventory update shows on the LIS inventory dashboard web page.

We'll then confirm these results for a minimum of 24 hours of 15-minute interval LIS inventory level updates.

Scenario C: Fate of unit

In this scenario, the facility will send a discard fate for a component and product.

Step 1: The facility will call the FateOfUnit web service method with a component discard payload.

You can verify the scenario when the:

  • web service method call is successful
  • LIS log page on the BloodNet website lists the fate details
  • fate summary page reflects the new component discard
  • user is also able to view the component discard fate details.

Note: You must repeat Scenario C for each of the UnitFate types your system uses against each of the product types your facility orders. For example, if you have 10 potential UnitFate types and you order red blood cells, platelets, frozen and immunoglobulin products, you need to test at least 40 individual scenarios. One for each UnitFate type with each product type.

We'll then confirm these results on at least 40 calls and 40 successful fate records.

Useful documents

Use these documents to help guide your verification testing process.

  • BloodNet LIS Facility Verification Template.xlsx
    89.36 KB
  • BloodNet LIS Vendor Verification Template.xlsx
    84.17 KB
  • BloodNet LIS Interface Vendor Integration Verification Checklist (PDF)
    242.05 KB
  • BloodNet LIS Interface Vendor Integration Verification Checklist (DOCX)
    767.8 KB
  • BloodNet LIS Interface Facility Integration Verification Checklist (PDF)
    243.77 KB
  • BloodNet LIS Interface Facility Integration Verification Checklist (DOCX)
    767.76 KB

Production credentials

Once your interface passes our vendor and facility certification, you'll get your LIS production service account and credentials.

If you need to add new users for the production environment, please:

  1. Have each new LIS administrator create their user account in BloodPortal(Opens in a new tab/window).
  2. Update and re-submit the LIS interface sign-up form.

Don't create new user accounts for anyone already registered on BloodPortal for the LIS testing and verification stages.

Interface updates

These LIS interfaces are in process at various stages of completion.

LISInterface status
Apollo (Sonic Healthcare)(Opens in a new tab/window)Currently under development
AUSLAB (Magentus)(Opens in a new tab/window)In production
BloodTrack (Haemonetics)(Opens in a new tab/window)Available for implementation
e-Blood (Magentus)(Opens in a new tab/window)In production
EVOLUTION vLab (Magentus)(Opens in a new tab/window)In production
MediPATH (LRS Health)(Opens in a new tab/window)Awaiting quote from vendor
Millennium (Oracle)(Opens in a new tab/window)In production
Pathology Laboratory System (Kestral)(Opens in a new tab/window)Currently under development
SoftBank (SCC Soft Computer)(Opens in a new tab/window)In production
TrakCare Laboratory (InterSystems)(Opens in a new tab/window)In production
Ultra (Cirdan)(Opens in a new tab/window)Available for implementation

Get in touch

For LIS interface support or questions, contact our Blood Operations Centre.

Our team is available 24/7 for live BloodNet-to-LIS interface support.

Phone: 1300 025 663 (13 000 BLOOD)

Email: support@blood.gov.au

Last updated: 27 Mar 2024

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback